Table 4.
Crude and adjusted associations between patient–doctor continuity and time to diagnosis of breast, colorectal, and lung cancer
| Covariate | Breast | Colorectal | Lung | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 | 
 | 
 | 
||||||||||
| Crude time ratio (95% CI) | P-value | Adjusted time ratio (95% CI) | P-value | Crude time ratio (95% CI) | P-value | Adjusted time ratio (95% CI) | P-value | Crude time ratio (95% CI) | P-value | Adjusted time ratio (95% CI) | P-value | |
| Patient–doctor continuitya | 1.01 (1.00 to 1.02) | 0.28 | 1.00 (0.99 to 1.01) | 0.90 | 1.00 (0.99 to 1.00) | 0.21 | 1.01 (1.01 to 1.02) | <0.01 | 0.98 (0.98 to 0.99) | <0.01 | 1.00 (0.99 to 1.00) | 0.33 | 
| 
 | ||||||||||||
| Number of consultations | 1.00 (1.00 to 1.00) | 0.67 | 1.00 (1.00 to 1.00) | 0.07 | 1.02 (1.02 to 1.02) | <0.01 | 1.02 (1.01 to 1.02) | <0.01 | 1.01 (1.01 to 1.02) | <0.01 | 1.01 (1.01 to 1.01) | <0.01 | 
| 
 | ||||||||||||
| Patient | ||||||||||||
| Age | 0.99 (0.99 to 0.99) | <0.01 | 0.99 (0.99 to 1.00) | <0.01 | 1.00 (1.00 to 1.00) | <0.01 | 1.00 (1.00 to 1.00) | <0.01 | 1.00 (1.00 to 1.00) | <0.01 | 1.00 (1.00 to 1.00) | 0.20 | 
| 
 | ||||||||||||
| Female | n/a | n/a | 1.08 (1.04 to 1.13) | <0.01 | 1.05 (1.01 to 1.09) | 0.03 | 1.06 (1.02 to 1.10) | <0.01 | 1.03 (0.99 to 1.07) | 0.12 | ||
| 
 | ||||||||||||
| Multimorbidity | 0.95 (0.93 to 0.97) | <0.01 | 0.97 (0.95 to 1.00 | 0.04 | 1.06 (1.04 to 1.08) | <0.01 | 0.99 (0.98 to 1.01) | 0.48 | 1.06 (1.05 to 1.08) | <0.01 | 1.02 (1.01 to 1.04) | <0.01 | 
| 
 | ||||||||||||
| Risk factorb | 0.96 (0.79 to 1.15) | 0.64 | 0.92 (0.77 to 1.10) | 0.35 | 1.22 (1.02 to 1.47) | 0.03 | 1.15 (0.96 to 1.37) | 0.13 | 1.30 (1.24 to 1.35) | <0.01 | 1.19 (1.14 to 1.24) | <0.01 | 
| 
 | ||||||||||||
| Current smoker | n/a | n/a | n/a | n/a | 0.95 (0.92 to 0.99) | 0.02 | 0.90 (0.85 to 0.95) | <0.01 | ||||
| 
 | ||||||||||||
| Ex-smoker | n/a | n/a | n/a | n/a | 1.03 (0.99 to 1.07) | 0.13 | 0.91 (0.86 to 0.95) | <0.01 | ||||
| 
 | ||||||||||||
| Index doctor | ||||||||||||
| Female | 0.92 (0.87 to 0.98) | 0.01 | 0.92 (0.86 to 0.98) | 0.01 | 1.02 (0.98 to 1.07) | 0.25 | 1.03 (0.99 to 1.08) | 0.15 | 1.02 (0.99 to 1.07) | 0.17 | 1.00 (0.96 to 1.04) | 0.96 | 
| 
 | ||||||||||||
| Status | ||||||||||||
| Salaried | 0.92 (0.68 to 1.25) | 0.59 | 0.91 (0.67 to 1.23) | 0.46 | 0.94 (0.74 to 1.19) | 0.72 | 0.86 (0.68 to 1.09) | 0.45 | 0.99 (0.80 to 1.24) | 0.08 | 1.02 (0.82 to 1.27) | 0.15 | 
| Locum | 1.05 (0.93 to 1.20) | 1.07 (0.94 to 1.21) | 0.97 (0.89 to 1.06) | 1.00 (0.92 to 1.10) | 0.92 (0.85 to 0.99) | 0.93 (0.86 to 1.00) | ||||||
| 
 | ||||||||||||
| Consultation type | ||||||||||||
| Surgery | 1.14 (1.02 to 1.29) | 0.04 | 1.13 (1.01 to 1.26) | 0.16 | 1.00 (0.91 to 1.08) | 0.17 | 0.99 (0.91 to 1.08) | 0.19 | 1.07 (0.98 to 1.16) | <0.01 | 1.08 (0.99 to 1.17) | <0.01 | 
| Telephone | 1.24 (0.94 to 1.63) | 1.22 (0.94 to 1.58) | 1.11 (0.98 to 1.27) | 1.02 (0.90 to 1.16) | 1.09 (0.97 to 1.24) | 1.01 (0.90 to 1.14) | ||||||
| Visit | 0.99 (0.82 to 1.20) | 1.15 (0.95 to 1.38) | 0.98 (0.88 to 1.10) | 0.91 (0.82 to 1.02) | 0.96 (0.86 to 1.06) | 0.92 (0.83 to 1.01) | ||||||
| 
 | ||||||||||||
| Symptoms/signs | ||||||||||||
| Number | 1.38 (0.94 to 2.01) | 0.10 | 1.42 (0.98 to 2.05) | 0.06 | 0.89 (0.81 to 0.98) | 0.03 | 0.96 (0.87 to 1.06) | 0.44 | 0.99 (0.91 to 1.07) | 0.74 | 0.99 (0.91 to 1.07) | 0.75 | 
| High-risk | 0.32 (0.28 to 0.37) | <0.01 | 0.34 (0.29 to 0.39) | <0.01 | 0.68 (0.65 to 0.71) | <0.01 | 0.72 (0.69 to 0.75) | <0.01 | 0.66 (0.61 to 0.70) | <0.01 | 0.70 (0.65 to 0.74) | <0.01 | 
Modified fraction-of-care index (f’); continuity defining period before and after index consultation.
Breast cancer: family history of breast cancer; colorectal cancer: ulcerative colitis; lung cancer: chronic obstructive pulmonary disease. n/a = not applicable.